Search

everythinglearnresearchcommunity

for

Search:↓

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

A new gel improves hair loss treatment by effectively delivering minoxidil and finasteride to the scalp.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib may help treat hair loss in children with alopecia areata.

Azithromycin and Roxithromycin can remove aging cells and may help with anti-aging.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Tamoxifen effectively treats gynecomastia without causing impotence.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Low-dose oral minoxidil is safe for alopecia patients, even those prone to edema.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Four new cases of gynecomastia (male breast enlargement) linked to finasteride (Propecia) have been found.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.